Both MOTS-c and AOD-9604 are highly popular products with great application value in the current bioactive peptide industry. Featuring unique physiological functions and promising application prospects, they are widely used in scientific research experiments, pharmaceutical R&D and other fields. As a 16-amino-acid peptide encoded by mitochondrial DNA, MOTS-c belongs to mitochondrial-derived peptides (MDPs). It is capable of crossing the blood-brain barrier. By boosting the biosynthesis of endogenous AMP analog AICAR, it activates the AMPK signaling pathway, thereby regulating multiple physiological processes including energy metabolism, antioxidation and anti-inflammation, boasting tremendous value for scientific research and clinical transformation.
|
|
|
|
|
|
|
|
The client in this cooperation is from the United States, marking their first business partnership with our company. Their core demand is to purchase MOTS-c(https://en.wikipedia.org/wiki/MOTS-c) and AOD-9604 for scientific research experiments.
The client initially learned about our products via our official website, then took the initiative to contact our sales team and put forward clear purchasing requirements.
Our team responded promptly and provided detailed quotations: AOD-9604 at USD 168 per box (5mg specification) and MOTS-c at USD 100 per box (10mg specification).
After confirming the quotes, the client adjusted the purchasing specifications, finally settling on AOD-9604 (10mg/box, USD 268) and MOTS-c (10mg/box, USD 100).
An additional shipping fee of USD 85 was required, bringing the total order value to USD 453. The client completed the payment via Bitcoin on May 14th, and submitted detailed payment screenshots and on-chain confirmation records.
After verifying the receipt of funds, we confirmed the delivery address with the client immediately and arranged order packing and delivery efficiently.
Product Application Analysis: Expansion of Scientific Research and Practical Scenarios
Main Applications of MOTS-c
Endowed with multi-target synergistic regulatory effects, MOTS-c enjoys extensive application scenarios mainly concentrated in scientific research and pharmaceutical development, which can be categorized into three major aspects:First, it serves as a tool for mechanism research. It is applied to explore the mechanism of mitochondria-nucleus communication and study the retrograde signaling pathways of nuclear gene regulation mediated by mtDNA-encoded peptides. It also facilitates the exploration of shared pathways linking metabolic disorders and aging, establishing a theoretical framework and experimental tools for researches on age-related metabolic diseases. For instance, activating the AMPK pathway with MOTS-c enables in-depth study on the correlation between mitochondrial function, cellular senescence and metabolic homeostasis, providing solid support for fundamental researches.
Second, it acts as an intervention agent in disease model studies and plays a vital role in various animal disease models. In the field of metabolic diseases, it is adopted for intervention researches on type 2 diabetes, obesity and non-alcoholic fatty liver disease (NAFLD). It improves glycolipid metabolism and enhances insulin sensitivity, offering novel ideas for disease treatment. In researches on aging-related disorders, it is used for studies on Alzheimer's disease, Parkinson's disease, sarcopenia and osteoporosis. Its anti-oxidative and anti-inflammatory effects alleviate nerve damage and tissue aging to slow down disease progression. In terms of inflammatory and fibrotic diseases, it is applied in researches on rheumatoid arthritis, pulmonary fibrosis and liver fibrosis, inhibiting inflammatory responses and tissue fibrosis to protect visceral functions. In mouse models of radiation-induced lung injury (RILI), MOTS-c activates the Nrf2 signaling pathway to relieve pulmonary inflammation and oxidative stress damage, presenting a potential new strategy for RILI prevention and treatment.
Third, it possesses great potential for pharmaceutical development. Thanks to its oral bioavailability, favorable safety profile and multi-target synergistic effects, MOTS-c stands out as a promising candidate molecule for new drug development. It has exerted satisfactory therapeutic effects in diverse animal models, and is expected to be developed into innovative drugs for metabolic diseases, aging-related disorders and inflammatory diseases following further clinical studies, with broad prospects for clinical translation. Moreover, engineered modification of MOTS-c such as R13A-MOTS-c can enhance cell membrane permeability, further elevate its therapeutic potential and enrich options for pharmaceutical research.
Main Applications of AOD-9604
AOD-9604 is primarily applied in scientific researches related to obesity and metabolism, and also sees expanding usage in cartilage repair studies, with specific applications as follows:
In obesity and metabolism researches, it is a crucial experimental reagent widely used in diet-induced and genetic obesity model studies. It accelerates fat decomposition and inhibits fat synthesis to reduce body weight and fat content in experimental animals, supporting researches on obesity mechanisms, lipid metabolism regulation and anti-obesity drug screening. Notably, AOD-9604 is more suitable for auxiliary fat loss researches on lean populations with optimized diet and exercise habits (body fat rate below 15% for males and 22% for females), rather than being the preferred research tool for obese groups. It mainly fine-tunes fat loss effects instead of achieving drastic weight loss.
In researches on metabolic syndrome, it is utilized for intervention studies on type 2 diabetes and non-alcoholic fatty liver disease. By improving insulin sensitivity and regulating glycolipid metabolism, it provides experimental evidence for the treatment of metabolic syndrome. In addition, combined use of AOD-9604 and tesamorelin helps preserve muscle mass during fat loss and prevent muscle loss among lean individuals under calorie deficit, forming more comprehensive experimental protocols for relevant researches.
In cartilage and bone repair researches, AOD-9604 promotes chondrocyte proliferation and matrix synthesis, and is applied in animal experiments and tissue engineering researches on osteoarthritis and joint injury repair, opening up new research directions and supplying experimental tools for cartilage regeneration. It must be emphasized that AOD-9604 is banned by the World Anti-Doping Agency (WADA) for competitive athletes, so relevant research applications must strictly comply with usage regulations.
Case Summary and Prospect
This maiden cooperation with the US client marks a significant milestone for our MOTS-c and AOD-9604 products to enter the global market, and fully recognizes our product quality, production standards and cross-border service capabilities. Throughout the cooperation, we have always prioritized client demands, responded swiftly to inquiries, delivered authentic product information, and efficiently completed order confirmation, payment verification and logistics arrangement, ensuring clients receive high-quality goods smoothly and achieve successful cooperation goals. This cooperation not only supplies qualified products meeting the client's research demands, but also accumulates valuable cross-border cooperation experience, laying a solid foundation for further global market expansion and overseas client service.Looking ahead, with the continuous advancement of the bioactive peptide industry, the application scope and market demand of MOTS-c and AOD-9604 will keep expanding.
We will consistently adhere to high-quality production concepts, optimize product quality and manufacturing techniques, upgrade cross-border service standards, and provide superior bioactive peptide products and comprehensive services for scientific research institutions and enterprises worldwide. Meanwhile, we will keep track of industrial trends, increase scientific research investment, drive technological innovation and clinical transformation of core products including MOTS-c, and boost the development of the bioactive peptide industry to achieve win-win development for both enterprises and clients. This first order from the US client is merely a starting point of our global market layout. In the future, we will continuously strengthen product competitiveness, expand overseas market layout, and enable more high-quality bioactive peptide products to fuel the development of global scientific research and pharmaceutical undertakings.
